Literature DB >> 14606073

Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study.

Xin Li1, Gan-Sheng Feng, Chuan-Sheng Zheng, Chen-Kai Zhuo, Xi Liu.   

Abstract

AIM: After transarterial chemoembolization (TACE), the residual cancer cells are under extensive hypoxic or even anoxic environment. Hypoxia can lead to adaptive responses. For example, angiogenesis will help these cells survive. In this study, we examined the effect of TACE on angiogenesis and expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) and to assess their relevance to Walker-256 transplanted hepatoma.
METHODS: Male Wistar rats were inoculated with Walker-256 tumor in the left lobe of liver. Angiography and transarterial chemoembolization were performed at d14 after transplantation. Sixty rats bearing walker-256 transplanted hepatoma were randomly divided into control group, arterial infusion group and TACE group. Each group consisted of twenty rats. Normal saline, 5-Fu, 5-Fu and lipiodol were infused through hepatic artery respectively. Two weeks after the infusion, staining of factor VIII, VEGF and b-FGF was performed by immunohistochemistry method in routine paraffin-embedded sections. Microvessel density (MVD) was counted in endothelial cells with positive factor VIII. Their expression levels were analyzed in conjunction with the pathologic features.
RESULTS: While a smaller tumor volume was found in TACE group (F=37.818, P<0.001), no statistical differences between MVD and expression of VEGF and b-FGF were found among the 3 groups. MVD of the control group, chemotherapy group and chemoemoblization group was 80.84+/-24.24, 83.05+/-20.29 and 85.20+/-23.91 (F=0.193, P=0.873), respectively. The positive expression of VEGF and b-FGF was 75%, 75%, 85% (chi2=0.449, P=0.799) and 30%, 25%, 30% (chi2=0.141, P=0.922), respectively. Statistical analysis revealed a positive correlation between the expression of VEGF and MVD (r=0.552, P<0.001).
CONCLUSION: There has been little influence of lipiodol chemoembolization on the formation of tumor angiogenesis, but the development of neovascularization and expression of VEGF play important roles in establishment of collateral circulation and reconstruction of blood supply of residual cancer tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606073      PMCID: PMC4656518          DOI: 10.3748/wjg.v9.i11.2445

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

Review 1.  The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.

Authors:  K J O'Byrne; A G Dalgleish; M J Browning; W P Steward; A L Harris
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

2.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

Review 3.  Biological consequences of tumor hypoxia.

Authors:  M Höckel; P Vaupel
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

4.  Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas.

Authors:  Randy L Jensen; Scott Soleau; Mihir K Bhayani; Dustin Christiansen
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

5.  [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].

Authors:  Z Lin; Z Ren; J Xia
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2000-07

6.  Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.

Authors:  Jae Kyun Lee; Young-Hwa Chung; Byung-Cheol Song; Jung Woo Shin; Won-Beom Choi; Soo Hyun Yang; Hyun-Ki Yoon; Kyu-Bo Sung; Yung Sang Lee; Dong Jin Suh
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

7.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].

Authors:  Guoliang Shao; Jianhua Wang; Kangrong Zhou; Zhiping Yan
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2002-06

9.  Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.

Authors:  T Higuchi; M Kikuchi; M Okazaki
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

10.  Cell proliferation, apoptosis and angiogenesis in gastric cancer and its hepatic metastases.

Authors:  Naohiko Koide; Akihito Nishio; Manabu Hiraguri; Ko Shimada; Nobuhiko Shimozawa; Kazuhiro Hanazaki; Shoji Kajikawa; Wataru Adachi; Jun Amano
Journal:  Hepatogastroenterology       Date:  2002 May-Jun
View more
  14 in total

1.  Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model.

Authors:  Yang Guo; Yue Zhang; Ning Jin; Rachel Klein; Jodi Nicolai; Robert J Lewandowski; Robert K Ryu; Reed A Omary; Andrew C Larson
Journal:  Invest Radiol       Date:  2012-02       Impact factor: 6.016

2.  Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.

Authors:  Hai-Lin Li; Wen-Bin Ji; Rui Zhao; Wei-Dong Duan; Yong-Wei Chen; Xian-Qiang Wang; Qiang Yu; Ying Luo; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

3.  Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.

Authors:  Jean-François Dufour; Hanno Hoppe; Markus H Heim; Beat Helbling; Olivier Maurhofer; Zsolt Szucs-Farkas; Ralph Kickuth; Markus Borner; Daniel Candinas; Bettina Saar
Journal:  Oncologist       Date:  2010-10-29

4.  Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Min Xu; Mb Majella Doyle; Babak Banan; Neeta Vachharajani; Xuanchuan Wang; Nael Saad; Kathryn Fowler; Elizabeth M Brunt; Yiing Lin; William C Chapman
Journal:  J Am Coll Surg       Date:  2017-04-09       Impact factor: 6.113

5.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

6.  Herpes simplex virus amplicon delivery of a hypoxia-inducible angiogenic inhibitor blocks capillary formation in hepatocellular carcinoma.

Authors:  Richard H Pin; Maura Reinblatt; William J Bowers; Howard J Federoff; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

7.  Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.

Authors:  Li Li; Jia-Ling Huang; Qi-Cai Liu; Pei-Hong Wu; Ran-Yi Liu; Yi-Xin Zeng; Wen-Lin Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

8.  Effective therapeutic management of hepatocellular carcinoma - on the basis of a clinical case.

Authors:  Joanna Omyła-Staszewska; Andrzej Deptała
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

9.  Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.

Authors:  Heng-Jun Gao; Li Xu; Yao-Jun Zhang; Min-Shan Chen
Journal:  Chin J Cancer       Date:  2013-12-11

10.  Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.

Authors:  Hyejung Cha; Hong In Yoon; Ik Jae Lee; Woong Sub Koom; Kwang-Hyub Han; Jinsil Seong
Journal:  J Radiat Res       Date:  2013-04-30       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.